技術指標
指標
數值
方向
MACD(12,26,9)
0.003
中性
RSI(14)
48.253
中性
STOCH(KDJ)(9,3,3)
28.894
賣出
ATR(14)
0.073
低波動
CCI(14)
-5.890
中性
Williams %R
43.529
買入
TRIX(12,20)
-0.005
賣出
StochRSI(14)
0.000
超賣
搜尋
TherapeuticsMD Inc
TXMD添加自選
2.030USD
0.0000.00%
收盤 07-31 16:00（美東）報價延遲15分鐘
23.50M總市值
130.46本益比TTM
關鍵數據
2.030今開
2.056最高
9.54K成交量
130.46本益比TTM
--本益比動
--股利TTM
0.08%換手率
2.030昨收
2.020最低
13.79K成交額
虧損本益比靜
0.87市淨率
0.00%股息率 TTM
0.23%ROA
2.95052週最高
0.51量比
-2.18M淨利潤
11.57M總股本
0.0156每股盈餘TTM
0.60Beta
0.32%ROE
0.98152週最低
1.79%振幅
100.00%毛利率
23.50M總市值
-0.78回報/風險
4.87%風險率
TradingKey TherapeuticsMD Inc股票評分
單位: USD 更新時間: 2026-07-31操作建議
TherapeuticsMD Inc當前公司基本面數據相對健康，增長潛力很大。當前估值合理，在藥品行業排名122/155位。機構持股佔比非常高，中期看，股價處於平穩狀態。近一個月，市場表現一般，但基本面評分較高。目前股價在壓力位和支撐位之間，可以做區間波段操作。
TherapeuticsMD Inc評分
壓力支撐
由於公司未披露，未能獲取相關數據
多維評測
本期評分
上期評分
公司輿情
過去24小時
熱度
過冷
過熱
看空
TherapeuticsMD Inc亮點
亮點風險
TherapeuticsMD, Inc. is a pharmaceutical royalty company, which primarily collects royalties from its licensees. It receives royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. It granted a license to commercialize IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands and assigned its exclusive license to commercialize ANNOVERA to Mayne Pharma. IMVEXXY (estradiol vaginal inserts) pharmaceutical product is for the treatment of moderate-to-severe dyspareunia. BIJUVA pharmaceutical product is a Food and Drug Administration (FDA)-approved bioidentical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus. ANNOVERA pharmaceutical product is a one-year ring-shaped contraceptive vaginal system (CVS).
業績高增長
公司營業收入穩步增長，連續3年增長132.10%
業績增長期
公司處於發展階段，最新年度總收入3.02M美元
估值高估
公司最新PE估值130.46，處於3年歷史高位
機構加倉
最新機構持股3.82M股，環比增加9.99%
詹姆斯·西蒙斯持倉
明星投資者詹姆斯·西蒙斯持倉，最新持倉0.00股
分析師目標
基於
0
分析師
--
評級
--
目標均價
--
漲幅空間
TherapeuticsMD Inc新聞
即將為您帶來更多新聞，敬請期待。 。 。
技術指標
移動平均線
指標
數值
方向
MA5
2.050
賣出
MA10
2.054
賣出
MA20
2.022
買入
MA50
2.053
賣出
MA100
2.081
賣出
MA200
1.965
買入
財務指標
每股收益
由於公司未披露，未能獲取相關數據
營業總收入
由於公司未披露，未能獲取相關數據
TherapeuticsMD Inc簡介
TherapeuticsMD, Inc. is a pharmaceutical royalty company, which primarily collects royalties from its licensees. It receives royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. It granted a license to commercialize IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands and assigned its exclusive license to commercialize ANNOVERA to Mayne Pharma. IMVEXXY (estradiol vaginal inserts) pharmaceutical product is for the treatment of moderate-to-severe dyspareunia. BIJUVA pharmaceutical product is a Food and Drug Administration (FDA)-approved bioidentical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus. ANNOVERA pharmaceutical product is a one-year ring-shaped contraceptive vaginal system (CVS).
公司代碼TXMD
公司TherapeuticsMD Inc
CEOWalker (Marlan D)
網址https://www.therapeuticsmd.com/
公司股東
相關品種
-0.53%
+0.27%
-2.51%
+0.32%
-1.45%
-0.92%
-0.64%
-0.82%
-8.79%
+0.52%
+0.68%
-0.95%
-0.71%
+0.44%
-1.08%
+3.29%
0.00%
-0.90%
+1.30%
-2.15%熱門品種
52378.000
+109.000 (+0.21%)
28160.900
-37.600 (-0.13%)
7475.100
+30.800 (+0.41%)
14749.000
-90.000 (-0.61%)
62852.000
-742.000 (-1.17%)
6365.400
-1.000 (-0.02%)
85.934
+2.764 (+3.32%)
308.910
-24.520 (-7.35%)
200.750
+5.710 (+2.93%)
4041.430
-61.400 (-1.50%)
常見問題
TherapeuticsMD Inc(TXMD)的當前股價是多少？
TherapeuticsMD Inc(TXMD)的當前股價是 2.04。
TherapeuticsMD Inc 的股票代碼是什麼？
TherapeuticsMD Inc的股票代碼是TXMD。
TherapeuticsMD Inc股票的52週最高點是多少？
TherapeuticsMD Inc股票的52週最高點是2.95。
TherapeuticsMD Inc股票的52週最低點是多少？
TherapeuticsMD Inc股票的52週最低點是0.98。
TherapeuticsMD Inc的市值是多少？
TherapeuticsMD Inc的市值是23.55M。
TherapeuticsMD Inc(TXMD)股票的每股收益（EPS TTM）是多少
TherapeuticsMD Inc(TXMD)股票的每股收益（EPS TTM）是-0.05。